Scotia Capital’s Globus Medical GMED Stock Holding History

Scotia Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,654	Closed	-$232K	–	940
2025 Q4	$232K	Buy	+2,654	New	+$201K	﹤0.01%	814

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scotia Capital's GMED Position: Q1 2026 in Review

Scotia Capital sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 2,654 shares — an estimated $232K sold.

Scotia Capital first reported a position in GMED in Q4 2025 and held it in 1 quarter. The position peaked at $232K in Q4 2025. 611 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Scotia Capital reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
Scotia Capital sold 2,654 Globus Medical shares in Q1 2026, an estimated $232K.
Scotia Capital first reported a position in Globus Medical in Q4 2025 and held it in 1 quarter.
Scotia Capital's Globus Medical position peaked at $232K in Q4 2025.
611 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.